Annual Total Long Term Liabilities
$68.86 M
-$20.85 M-23.25%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual total long term liabilities is $68.86 million, with the most recent change of -$20.85 million (-23.25%) on December 31, 2023.
- During the last 3 years, PRQR annual total long term liabilities has risen by +$29.64 million (+75.59%).
- PRQR annual total long term liabilities is now -23.25% below its all-time high of $89.71 million, reached on December 31, 2022.
Performance
PRQR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$47.17 M
-$4.20 M-8.17%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly total long term liabilities is $47.17 million, with the most recent change of -$4.20 million (-8.17%) on September 1, 2024.
- Over the past year, PRQR quarterly long term liabilities has dropped by -$25.92 million (-35.46%).
- PRQR quarterly long term liabilities is now -47.42% below its all-time high of $89.71 million, reached on December 31, 2022.
Performance
PRQR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PRQR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.3% | -35.5% |
| 3 y3 years | +75.6% | +58.8% |
| 5 y5 years | +541.3% | +58.8% |
PRQR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.3% | at low | -47.4% | +58.8% |
| 5 y | 5-year | -23.3% | +383.7% | -47.4% | +756.0% |
| alltime | all time | -23.3% | >+9999.0% | -47.4% | +3346.8% |
ProQR Therapeutics NV Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.17 M(-8.2%) |
| Jun 2024 | - | $51.36 M(-12.9%) |
| Mar 2024 | - | $59.00 M(-14.3%) |
| Dec 2023 | $68.86 M(-23.2%) | $68.86 M(-5.8%) |
| Sep 2023 | - | $73.08 M(-8.5%) |
| Jun 2023 | - | $79.89 M(-10.8%) |
| Mar 2023 | - | $89.58 M(-0.1%) |
| Dec 2022 | $89.71 M(+15.2%) | $89.71 M(+202.0%) |
| Sep 2022 | - | $29.70 M(-56.2%) |
| Jun 2022 | - | $67.84 M(-8.3%) |
| Mar 2022 | - | $74.00 M(-4.9%) |
| Dec 2021 | $77.84 M(+98.5%) | $77.84 M(+105.7%) |
| Sep 2021 | - | $37.84 M(-2.0%) |
| Jun 2021 | - | $38.60 M(+3.1%) |
| Mar 2021 | - | $37.44 M(-4.5%) |
| Dec 2020 | $39.21 M(+175.4%) | $39.21 M(+6.8%) |
| Sep 2020 | - | $36.73 M(+566.6%) |
| Jun 2020 | - | $5.51 M(-62.0%) |
| Mar 2020 | - | $14.48 M(+1.7%) |
| Dec 2019 | $14.24 M | $14.24 M(+23.8%) |
| Sep 2019 | - | $11.50 M(-7.8%) |
| Jun 2019 | - | $12.47 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $12.48 M(+16.3%) |
| Dec 2018 | $10.74 M(+69.4%) | $10.74 M(+46.1%) |
| Sep 2018 | - | $7.35 M(+5.5%) |
| Jun 2018 | - | $6.96 M(-1.4%) |
| Mar 2018 | - | $7.06 M(+11.4%) |
| Dec 2017 | $6.34 M(+5.3%) | $6.34 M(-17.0%) |
| Sep 2017 | - | $7.64 M(+9.7%) |
| Jun 2017 | - | $6.96 M(+11.5%) |
| Mar 2017 | - | $6.24 M(+3.6%) |
| Dec 2016 | $6.02 M(+14.2%) | $6.02 M(+48.1%) |
| Sep 2016 | - | $4.07 M(-30.6%) |
| Jun 2016 | - | $5.86 M(+0.5%) |
| Mar 2016 | - | $5.83 M(+10.5%) |
| Dec 2015 | $5.27 M(+53.3%) | $5.27 M(+8.2%) |
| Sep 2015 | - | $4.88 M(+2.7%) |
| Jun 2015 | - | $4.75 M(+51.6%) |
| Mar 2015 | - | $3.13 M(-9.0%) |
| Dec 2014 | $3.44 M(+151.4%) | $3.44 M(-2.9%) |
| Sep 2014 | - | $3.54 M(-4.4%) |
| Jun 2014 | - | $3.70 M(+170.7%) |
| Dec 2013 | $1.37 M(+977.5%) | $1.37 M |
| Dec 2012 | $127.00 K | - |
FAQ
- What is ProQR Therapeutics NV annual total long term liabilities?
- What is the all time high annual total long term liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual total long term liabilities year-on-year change?
- What is ProQR Therapeutics NV quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly long term liabilities year-on-year change?
What is ProQR Therapeutics NV annual total long term liabilities?
The current annual total long term liabilities of PRQR is $68.86 M
What is the all time high annual total long term liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual total long term liabilities is $89.71 M
What is ProQR Therapeutics NV annual total long term liabilities year-on-year change?
Over the past year, PRQR annual total long term liabilities has changed by -$20.85 M (-23.25%)
What is ProQR Therapeutics NV quarterly total long term liabilities?
The current quarterly long term liabilities of PRQR is $47.17 M
What is the all time high quarterly long term liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly total long term liabilities is $89.71 M
What is ProQR Therapeutics NV quarterly long term liabilities year-on-year change?
Over the past year, PRQR quarterly total long term liabilities has changed by -$25.92 M (-35.46%)